| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.37▲ | 1.36▲ | 1.34▲ | 1.23▲ | 1.39▼ |
| MA10 | 1.36▲ | 1.32▲ | 1.28▲ | 1.26▲ | 1.45▼ |
| MA20 | 1.37▲ | 1.27▲ | 1.24▲ | 1.37▲ | 1.80▼ |
| MA50 | 1.31▲ | 1.21▲ | 1.21▲ | 1.48▼ | 25.62▼ |
| MA100 | 1.24▲ | 1.22▲ | 1.32▲ | 1.86▼ | 23.62▼ |
| MA200 | 1.19▲ | 1.34▲ | 1.41▼ | 12.79▼ | 37.19▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.010▲ | 0.019▲ | 0.001▲ | 1.365▲ |
| RSI | 64.280▲ | 75.640▲ | 73.015▲ | 49.989▼ | 36.347▼ |
| STOCH | 69.524 | 93.438▲ | 91.558▲ | 38.315 | 15.658▼ |
| WILL %R | -14.286▲ | -3.030▲ | -2.381▲ | -34.615 | -79.641▼ |
| CCI | 130.968▲ | 86.542 | 130.906▲ | 16.799 | -122.504▼ |
|
Monday, November 10, 2025 06:15 AM
The MarketWatch News Department was not involved in the creation of this content. First data on Aptevo's new molecule presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting SEATTLE ...
|
|
Sunday, November 09, 2025 09:05 PM
SEATTLE, WASHINGTON / ACCESS Newswire / November 10, 2025 / Aptevo Therapeutics ("Aptevo" or the "Company") (Nasdaq:APVO), a clinical-stage biotechnology company advancing differentiated ...
|
|
Tuesday, September 16, 2025 05:30 AM
The MarketWatch News Department was not involved in the creation of this content. No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/11/25 | 1.30 | 1.39 | 1.2901 | 1.38 | 553,194 |
| 26/11/25 | 1.225 | 1.29 | 1.205 | 1.28 | 468,879 |
| 25/11/25 | 1.19 | 1.2199 | 1.15 | 1.20 | 548,949 |
| 24/11/25 | 1.14 | 1.19 | 1.12 | 1.18 | 423,418 |
| 21/11/25 | 1.10 | 1.14 | 1.04 | 1.13 | 949,901 |
| 20/11/25 | 1.25 | 1.25 | 1.07 | 1.08 | 991,257 |
| 19/11/25 | 1.30 | 1.31 | 1.21 | 1.22 | 673,151 |
| 18/11/25 | 1.34 | 1.35 | 1.27 | 1.32 | 818,905 |
| 17/11/25 | 1.40 | 1.425 | 1.35 | 1.37 | 508,281 |
| 14/11/25 | 1.41 | 1.43 | 1.38 | 1.41 | 711,617 |
|
|
||||
|
|
||||
|
|